Not currently recruiting at UC Irvine
Study of ET140203 T Cells in Adults With Advanced Hepatocellular Carcinoma (ARYA-1)
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at Irvine, California and other locations
- Dates
- study startedestimated completion
- Principal Investigator
- by Farshid Dayyani, MD, Phd
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Lead Scientist at UC Irvine
- Farshid Dayyani, MD, Phd
Clinical Professor, Medicine. Authored (or co-authored) 49 research publications.
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Eureka Therapeutics Inc.
- ID
- NCT04502082
- Phase
- Phase 1/2
- Study Type
- Interventional
- Last Updated